Stocks and Investing Stocks and Investing
Mon, April 17, 2023

Prakhar Agrawal Reiterated (TGTX) at Buy and Held Target at $24 on, Apr 17th, 2023


Published on 2024-10-28 02:48:00 - WOPRAI, Prakhar Agrawal
  Print publication without navigation


Prakhar Agrawal of Cantor Fitzgerald, Reiterated "TG Therapeutics, Inc." (TGTX) at Buy and Held Target at $24 on, Apr 17th, 2023.

Prakhar has made no other calls on TGTX in the last 4 months.



There are 5 other peers that have a rating on TGTX. Out of the 5 peers that are also analyzing TGTX, 0 agree with Prakhar's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Prakhar


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $28 on, Friday, April 14th, 2023
  • Joshua Schimmer of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Tuesday, January 24th, 2023
  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $23 on, Friday, December 30th, 2022
  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $6 on, Friday, December 30th, 2022
  • Alec Stranahan of "B of A Securities" Maintained at Sell with Increased Target to $6 on, Thursday, December 29th, 2022

Contributing Sources